RFK Jr. Says Vaccinating Birds Against Avian Flu Will Create ‘Mutation Factories’

RFK Jr. Warns Against Bird Vaccinations Amid Avian Flu Outbreak

Robert F. Kennedy Jr. has raised concerns about the implications of vaccinating birds against the avian flu, suggesting that it could potentially create ‘mutation factories’. Kennedy, who serves as the Secretary of the U.S. Department of Health and Human Services, shared his views on the matter during an interview with Fox News host Sean Hannity on March 11. He emphasised that the avian flu is a virus that is inherent in wild bird populations, leading to its transmission to domestic flocks.

Kennedy pointed out that the use of a ‘leaky vaccine’, which does not offer complete protection against the disease, could inadvertently promote the mutation of the virus within bird populations. This mutation, he argued, increases the risk of the virus jumping to other animals, including humans. He highlighted that prominent health agencies such as the National Institute of Health (NIH), Centers for Disease Control (CDC), and Food and Drug Administration (FDA) have advised against bird vaccinations due to these concerns.

The complexities surrounding avian flu vaccinations were further discussed in a study published in the journal Plos Biology in 2020, which noted that many vaccines used in livestock and humans exhibit leakiness, wherein they may prevent symptoms but not the infection or transmission of the virus. While Europe has approved two vaccines for preventing avian flu in chickens, the focus is primarily on administering them during outbreaks to minimise their impact.

In the United States, the current approach to managing avian flu outbreaks involves culling infected animals as a preventive measure. Kennedy questioned the efficacy of this strategy, suggesting that isolating the affected birds and allowing the disease to run its course could potentially identify resilient individuals with genetic immunity. These birds could then be selectively bred to develop a more robust immune population.

Moreover, Kennedy proposed conducting intensive tests on these immune bird populations to explore potential therapeutic drugs that could also benefit humans affected by the avian flu. By prioritising research and treatments tailored to the specific genetics of resilient birds, he believes that a more sustainable solution to combating the avian flu can be developed. This approach, he argues, could also help mitigate the economic repercussions of mass culling, such as the recent egg crisis that has stemmed from widespread bird infections.

As the avian flu crisis continues to threaten both animal and human populations, Kennedy’s stance on avoiding mass bird vaccinations in favour of targeted breeding and research initiatives underscores the need for a nuanced and proactive approach to disease management. By prioritising the natural immunity of bird populations and leveraging their genetic resilience, there may be a more sustainable and effective path towards addressing the challenges posed by avian flu outbreaks.